Advances in MRI have enabled better understanding for diagnosing epilepsy, while multimodality techniques allow for better information for surgery and post-surgery follow up, according to experts presenting at ECR 2011.
Advances in MRI have enabled better understanding for diagnosing epilepsy, while multimodality techniques allow for better information for surgery and post-surgery follow up, according to experts presenting at ECR 2011.
The cause of epilepsy, a chronic nuerological disorder, is a mystery, but over the last 30 years, MRI advances have helped physicians determine a large number of underlying causes, particularly for intractable epilepsy, experts said.
“If there is a field where imaging has had an impact, it is certainly in patients with intractable epilepsy,” said Beatriz Gómez-Ansón, head of the neuroradiology unit at Hospital Sant Pau in Barcelona, who chaired a refresher course at the congress this week.
Intractable epilepsy, which affects 5 percent of epilepsy patients, is only treatable with surgery. Through imaging, physicians have determined that intractable epilepsy is mainly caused by non-neoplastic conditions, such as hippocampus sclerosis, or abnormalities of cortical development, either congenital or related to an infancy condition, according to a release about the session.
Imaging also now helps with treatment planning. For example, MRI usually provides enough information to show where a tumor is located. But when MRI fails to reveal focal, structural pathology as the putative aetiology for the seizures, other modalities may be considered, researchers said.
“Ictal SPECT may help to identify focal areas of hyperperfusion – ictal zones – while functional MRI is used to determine language laterality (dominant hemisphere) and localize eloquent cortical structures to aid the planning of the surgical approach,” Doctor Lars Stenberg, radiologist at Lund University Hospital, said in the release.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).